The Covington Release:cov & b
Here’s the core of the Leafly piece and it’s really worth reading all of it as they make some pertinent points.
Sharma’s comments rest on the assumption that the legalization of hemp automatically means the legalization of hemp-derived CBD. But all is not legal rainbows and unicorns for CBD producers just yet.
The DEA, for one, still considers CBD to be a Schedule I controlled substance.
A DEA clarification issued in March 2016, in response to a petition filed by Hemp Industries Association and others about marijuana, indicated that some CBD is still a Schedule I substance:
“As the scientific literature indicates, cannabinoids, such as tetrahydrocannabinols (THC), cannabinols (CBN) and cannabidiols (CBD), are found in the parts of the cannabis plant that fall within the CSA definition of marijuana, such as the flowering tops, resin, and leave. According to the scientific literature, cannabinoids are not found in the parts of the cannabis plant that are excluded from the CSA definition of marijuana.” The CSA defines marijuana as “all parts of the plant Cannabis sativa L., whether growing or not; the seeds thereof; the resin extracted from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds or resin.”
But the clarification did say that trace amounts of CBD, if derived from stalks or seeds, were legal.
December 14, 2018
At long last, the hemp industry can revel in landmark legislation which has been years in the making. For many years, hemp industry stakeholders have worked alongside bipartisan members of Congress – like Senate Majority leader Mitch McConnell, Representative Jared Polis, and many more – to pass legislation restoring hemp’s appropriate place within U.S. agriculture and beyond.
Where is the 2018 Version of the Farm Bill?
Earlier this week, the conference committee – a committee convened to reconcile differences between House and Senate versions of the bill – issued its final report and reconciled version of the Agricultural Improvement Act of 2018 – otherwise known as the 2018 version of the Farm Bill (the “Farm Bill”). In quick succession, the Senate and the House then approved the the Farm Bill, and we now wait with bated breath for the President’s anticipated signature. Final approval is expected imminently.
What Does the Farm Bill Practically Do?
Perhaps the greatest impact of the Farm Bill is the galvanization of momentum across the board and throughout the supply chain and ancillary stakeholders:
– Providing comfort to retailers in bringing products to retail shelves en masse;
– Providing comfort to banks, payment processors, insurers to provide services to hemp industry stakeholders;
– Encourage investment and infusions of capital into businesses and infrastructure for both fiber-, seed- and oil-based uses of hemp;
– Instigate federal, state and local agencies to act affirmatively to authorize and regulate hemp; and
– Importantly, quiets any question as to the Drug Enforcement Administration’s (“DEA”) lack of authority with respect to hemp
What Does the Farm Bill Legally Do?
Once officially signed into law, it is important for us to take a deep breath and celebrate this historic moment and understand the momentous progress the 2018 version of the Farm Bill achieves. Specifically, the Farm Bill serves to clarify and affirm the rightful place of raw hemp as an agricultural commodity, alongside corn and wheat. Notably, these hemp provisions in the Farm Bill state, in part:
Where Do We Go From Here?
At the same time, though the passage of the Farm Bill is incredible news, it is similarly important to remember the work left to be done, which will of course take time – months, if not more than a year – to roll out:
– USDA must now take the reigns in implementing regulations and/or reviewing and approving state-authorized “plans” for cultivation;
– There is likely to be a cascade effect at the state level to pass state-level “plans” and implement regulations consistent with the Farm Bill;
– Attention now turns to FDA with respect to ensuring that hemp-derived cannabinoids – including extracts containing cannabidiol – are to be treated as permissible ingredients; and
– Resolve bumps in the road that are likely to arise as federal, state and local legislators and regulators work to implement the tenets of the Farm Bill over the coming months and years.
To that end, once we collectively take a moment to deservedly celebrate this momentous occasion, we look forward to rolling up our sleeves and continuing to work alongside hemp industry stakeholders and government officials in ensuring appropriate and sensible regulation at federal, state and local levels. The opportunities many in the industry have long awaited are at the cusp of being realized and this landmark announcement will certainly go down as a seismic policy shift in our nation’s history.
HLG Hemp Practice Group
Robert Hoban, David Bush, Patrick Goggin, Garrett Graff, Darren Kaplan, Matthew Smith, Esqs.
TORONTO and MISSISSAUGA, Ontario, Dec. 13, 2018 (GLOBE NEWSWIRE) -- PRESS RELEASE -- The Green Organic Dutchman Holdings Ltd. and HelloMD, an online cannabis healthcare company, have announced a partnership to streamline TGOD’s medical cannabis onboarding experience.
TGOD will begin selling its certified-organic cannabis to medical patients in late January 2019. The integration of HelloMD's online clinic services will enhance TGOD’s approach to patient care.
HelloMD provides a solution for patients looking to access medical cannabis in Canada online. By leveraging HelloMD’s white-label patient services platform, TGOD will ensure patients have access to independent, practitioner-led advice and education about medical cannabis. Prospective patients can connect online with a licensed practitioner seven days a week from the comfort of their preferred location. Patients who obtain appropriate documentation can purchase from TGOD’s broad range of premium medical cannabis products.
“At TGOD, 'Making Life Better' is not just our brand tagline, it’s our ongoing commitment to every consumer,” said Andrew Pollock, vice president of marketing at TGOD. “Patients deserve premium organic cannabis and through the partnership with HelloMD, we are pleased to provide increased access to TGOD’s product lines with the highest level of customer service and functionality to our patients.”
“The journey from canna-curious, to feeling better, can be complex for Canadians considering medical cannabis,” said Larry Lisser, SVP of business development at HelloMD. “HelloMD’s services enable our partners to improve their patients’ experience by streamlining the onboarding process. In this joint effort with TGOD, we will ensure patients receive the best personalized advice on organic medical cannabis to move forward."